COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 718: Articles 7171-7180  | Next

Impact of non-pharmaceutical interventions on COVID-19 incidence and deaths: cross-national natural experiment in 32 European countries
Costa, D., Rohleder, S., Bozorgmehr, K.
10.1101/2022.07.11.22277491 — Posted: 2022-07-12
Changes in General Practice use and costs with COVID-19 and telehealth initiatives
Butler, D. C., Joshy, G., Douglas, K. A., Bin-Sayeed, M.-S., Welsh, J., Douglas, A., Korda, R. J.
10.1101/2022.07.11.22277516 — Posted: 2022-07-12
Type 1 and type 2 diabetes mellitus: Clinical outcomes due to COVID-19. Protocol of a systematic literature review
Perez Bedoya, J. P., Mejia Munoz, A., Barengo, N. C., Diaz Valencia, P. A.
10.1101/2022.07.11.22277475 — Posted: 2022-07-12
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022
Chen, X., Yan, X., Sun, K., Zheng, N., Sun, R., Zhou, J., Deng, X., Zhuang, T., Cai, J., Zhang, J., Ajelli, M., Yu, H.
10.1101/2022.07.11.22277504 — Posted: 2022-07-12
The uncoupling of all-cause excess mortality from Covid-19 cases and associated hospitalizations in late winter and spring of 2022 in a highly vaccinated state.
Faust, J., Renton, B., Chen, A. J., Du, C., Liang, C., Li, S.-X., Lin, Z., Krumholz, H.
10.1101/2022.07.07.22277315 — Posted: 2022-07-12
Effect of Stay-at-Home Orders and Other COVID-Related Policies on Trauma Hospitalization Rates and Disparities in the United States: A Statewide Time-Series Analysis
Strassle, P. D., Kinlaw, A. C., Ko, J. S., Quintero, S., Bonilla, J., Ponder, M., Napoles, A. M., Schiro, S. E.
10.1101/2022.07.11.22277511 — Posted: 2022-07-12
Development of an Accurate and Rapid Antigen Assay for COVID-19 Diagnostics Using Saliva
Troup, C., Mukhopadhyay, D., Chakrabarty, T., Madan, A., Satyanarayana, S., Mehta, S., Dwarakanath, S.
10.1101/2022.07.10.22277467 — Posted: 2022-07-12
Age stratified seroprevalence of antibodies against SARS CoV 2 in the pre and post vaccination era, February 2020 to March 2022, Japan
Yamayoshi, S., Iwatsuki-Horimoto, K., Okuda, M., Ujie, M., Yasuhara, A., Murakami, J., Duong, C., Hamabata, T., Ito, M., Chiba, S., Kobayashi, R., Takahash, S., Mitamura, K., Hagihara, M., Shibata, A., Uwamino, Y., Hasegawa, N., Ebina, T., Izumi, A., Kato, H., Nakajima, H., Sugaya, N., Seki, Y., Iqbal, A., Kamimaki, I., Yamazaki, M., Kawaoka, Y., Furuse, Y.
10.1101/2022.07.11.22277481 — Posted: 2022-07-12
COVID-19 Vaccination Uptake and Self-Reported Side Effects among Healthcare Workers in Mbale City Eastern Uganda
Akech, G. M. M., Kanyike, A. M., Nassozi, A. G., Aguti, B., Nakawuki, A. W., Kimbugwe, D., Kiggundu, J., Maiteki, R., Mukyala, D., Bongomin, F., Obakiro, S. B., Rebecca, N., Iramiot, J. S.
10.1101/2022.07.11.22277490 — Posted: 2022-07-12
Microbubbles for improved nucleic acid extraction in wastewater samples for viral RNA detection
Wegner, C. J., Roussey, J., Carey, M., Macintyre, B., Snow, T., Sieglaff, D., Bridi, A., Battiste, S., Livi, C. B., McNaughton, B.
10.1101/2022.07.10.22277342 — Posted: 2022-07-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).